Loading…

Pharmacokinetics of single-dose cefuroxime in porcine intervertebral disc and vertebral cancellous bone determined by microdialysis

Abstract Background Pyogenic spondylodiscitis is associated with prolonged antimicrobial therapy and high relapse rates. Nevertheless, tissue pharmacokinetic studies of relevant antimicrobials in both prophylactic and therapeutic situations are still sparse. Previous approaches based on bone biopsy...

Full description

Saved in:
Bibliographic Details
Published in:The spine journal 2016-03, Vol.16 (3), p.432-438
Main Authors: Hanberg, Pelle, MD-student, Bue, Mats, MD-student, PhD-student, Birke Sørensen, Hanne, MD, PhD, Søballe, Kjeld, Professor, MD, DMSc, Tøttrup, Mikkel, MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c417t-30504f00a7fc1b07b616b67154933dd9ab14f5d22c2c6b95793e00c8d601214f3
cites cdi_FETCH-LOGICAL-c417t-30504f00a7fc1b07b616b67154933dd9ab14f5d22c2c6b95793e00c8d601214f3
container_end_page 438
container_issue 3
container_start_page 432
container_title The spine journal
container_volume 16
creator Hanberg, Pelle, MD-student
Bue, Mats, MD-student, PhD-student
Birke Sørensen, Hanne, MD, PhD
Søballe, Kjeld, Professor, MD, DMSc
Tøttrup, Mikkel, MD, PhD
description Abstract Background Pyogenic spondylodiscitis is associated with prolonged antimicrobial therapy and high relapse rates. Nevertheless, tissue pharmacokinetic studies of relevant antimicrobials in both prophylactic and therapeutic situations are still sparse. Previous approaches based on bone biopsy and discectomy exhibit important methodological limitations. Purpose The objective of this study was to assess the C3–C4 intervertebral disc (IVD), C3 vertebral body cancellous bone, and subcutaneous adipose tissue (SCT) pharmacokinetics of cefuroxime by use of microdialysis in a large animal model. Study Design This was a single-dose, dense sampling large animal study of cefuroxime spine penetration. Methods Ten female pigs were assigned to receive 1,500 mg of cefuroxime intravenously over 15 minutes. Measurements of cefuroxime were obtained from plasma, SCT, vertebral cancellous bone, and IVD for 8 hours thereafter. Microdialysis was applied for sampling in solid tissues. Results For both IVD and vertebral cancellous bone, the area under the concentration curve from zero to the last measured value (AUC0–last ) was significantly lower than that of free plasma. As estimated by the ratio of tissue AUC0–last to plasma AUC0–last , tissue penetration (95% confidence interval) of cefuroxime was significantly incomplete for the IVD 0.78 (0.57; 0.99), whereas for vertebral cancellous bone 0.78 (0.51; 1.04) and SCT 0.94 (0.73; 1.15) it was not. The penetration of cefuroxime from plasma to the IVD was delayed, and the maximal concentration and the elimination of cefuroxime were also reduced compared with both SCT and vertebral cancellous bone. Because of this delay in elimination of cefuroxime, the time with concentrations above the minimal inhibitory concentration (T>MIC ) was significantly longer in the IVD compared with the remaining compartments up to MICs of 6 µg/mL. Conclusions Microdialysis was successfully applied for serial assessment of the concentration of cefuroxime in the IVD and the vertebral cancellous bone. Penetration of cefuroxime from plasma to IVD was found to be incomplete and delayed, but because of a prolonged elimination, superior T>MIC was found in the IVD up to MICs of 6 µg/mL.
doi_str_mv 10.1016/j.spinee.2015.11.031
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1780513781</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1529943015016927</els_id><sourcerecordid>1780513781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-30504f00a7fc1b07b616b67154933dd9ab14f5d22c2c6b95793e00c8d601214f3</originalsourceid><addsrcrecordid>eNqFkk9v1DAQxSMEoqXwDRDykUvCjJ3EyQUJVfypVAkk4Gw59gS8TeLFTir2zBdnVluKxIWTR_Z7M88_TVE8R6gQsH21q_I-LESVBGwqxAoUPijOsdNdia2SD7luZF_2tYKz4knOOwDoNMrHxZlsWwl93Z4Xvz59t2m2Lt5wrzW4LOIocli-TVT6mEk4GrcUf4aZRFjEPibHQi5XSreUVhqSnYQP2Qm7ePH3ytnF0TTFLYshssMTO2b2ejEcxBxcij7Y6ZBDflo8Gu2U6dndeVF8fff2y-WH8vrj-6vLN9elq1GvpYIG6hHA6tHhAHposR1ajU3dK-V9bwesx8ZL6aRrh77RvSIA1_kWUPKTuihenvruU_yxUV7NzLk5pF2IcxrUHTSodIcsrU9SjplzotHsU5htOhgEc8RvduaE3xzxG0TD-Nn24m7CNszk701_eLPg9UlA_M_bQMlkF4hJ-ZDIrcbH8L8J_zZwU1iCs9MNHSjv4pYWZmjQZGnAfD6uwHEDsOGWvdTqNwEVr4U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780513781</pqid></control><display><type>article</type><title>Pharmacokinetics of single-dose cefuroxime in porcine intervertebral disc and vertebral cancellous bone determined by microdialysis</title><source>ScienceDirect Journals</source><creator>Hanberg, Pelle, MD-student ; Bue, Mats, MD-student, PhD-student ; Birke Sørensen, Hanne, MD, PhD ; Søballe, Kjeld, Professor, MD, DMSc ; Tøttrup, Mikkel, MD, PhD</creator><creatorcontrib>Hanberg, Pelle, MD-student ; Bue, Mats, MD-student, PhD-student ; Birke Sørensen, Hanne, MD, PhD ; Søballe, Kjeld, Professor, MD, DMSc ; Tøttrup, Mikkel, MD, PhD</creatorcontrib><description>Abstract Background Pyogenic spondylodiscitis is associated with prolonged antimicrobial therapy and high relapse rates. Nevertheless, tissue pharmacokinetic studies of relevant antimicrobials in both prophylactic and therapeutic situations are still sparse. Previous approaches based on bone biopsy and discectomy exhibit important methodological limitations. Purpose The objective of this study was to assess the C3–C4 intervertebral disc (IVD), C3 vertebral body cancellous bone, and subcutaneous adipose tissue (SCT) pharmacokinetics of cefuroxime by use of microdialysis in a large animal model. Study Design This was a single-dose, dense sampling large animal study of cefuroxime spine penetration. Methods Ten female pigs were assigned to receive 1,500 mg of cefuroxime intravenously over 15 minutes. Measurements of cefuroxime were obtained from plasma, SCT, vertebral cancellous bone, and IVD for 8 hours thereafter. Microdialysis was applied for sampling in solid tissues. Results For both IVD and vertebral cancellous bone, the area under the concentration curve from zero to the last measured value (AUC0–last ) was significantly lower than that of free plasma. As estimated by the ratio of tissue AUC0–last to plasma AUC0–last , tissue penetration (95% confidence interval) of cefuroxime was significantly incomplete for the IVD 0.78 (0.57; 0.99), whereas for vertebral cancellous bone 0.78 (0.51; 1.04) and SCT 0.94 (0.73; 1.15) it was not. The penetration of cefuroxime from plasma to the IVD was delayed, and the maximal concentration and the elimination of cefuroxime were also reduced compared with both SCT and vertebral cancellous bone. Because of this delay in elimination of cefuroxime, the time with concentrations above the minimal inhibitory concentration (T&gt;MIC ) was significantly longer in the IVD compared with the remaining compartments up to MICs of 6 µg/mL. Conclusions Microdialysis was successfully applied for serial assessment of the concentration of cefuroxime in the IVD and the vertebral cancellous bone. Penetration of cefuroxime from plasma to IVD was found to be incomplete and delayed, but because of a prolonged elimination, superior T&gt;MIC was found in the IVD up to MICs of 6 µg/mL.</description><identifier>ISSN: 1529-9430</identifier><identifier>EISSN: 1878-1632</identifier><identifier>DOI: 10.1016/j.spinee.2015.11.031</identifier><identifier>PMID: 26620946</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Anti-Bacterial Agents - pharmacokinetics ; Cefuroxime ; Cefuroxime - pharmacokinetics ; Cervical Vertebrae - chemistry ; Female ; Infusions, Intravenous ; Intervertebral disc ; Intervertebral Disc - chemistry ; Microbial Sensitivity Tests ; Microdialysis ; Models, Animal ; Orthopedics ; Pharmacokinetics ; Subcutaneous Fat - chemistry ; Swine ; Tissue penetration ; Vertebra</subject><ispartof>The spine journal, 2016-03, Vol.16 (3), p.432-438</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-30504f00a7fc1b07b616b67154933dd9ab14f5d22c2c6b95793e00c8d601214f3</citedby><cites>FETCH-LOGICAL-c417t-30504f00a7fc1b07b616b67154933dd9ab14f5d22c2c6b95793e00c8d601214f3</cites><orcidid>0000-0002-6845-1874</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26620946$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hanberg, Pelle, MD-student</creatorcontrib><creatorcontrib>Bue, Mats, MD-student, PhD-student</creatorcontrib><creatorcontrib>Birke Sørensen, Hanne, MD, PhD</creatorcontrib><creatorcontrib>Søballe, Kjeld, Professor, MD, DMSc</creatorcontrib><creatorcontrib>Tøttrup, Mikkel, MD, PhD</creatorcontrib><title>Pharmacokinetics of single-dose cefuroxime in porcine intervertebral disc and vertebral cancellous bone determined by microdialysis</title><title>The spine journal</title><addtitle>Spine J</addtitle><description>Abstract Background Pyogenic spondylodiscitis is associated with prolonged antimicrobial therapy and high relapse rates. Nevertheless, tissue pharmacokinetic studies of relevant antimicrobials in both prophylactic and therapeutic situations are still sparse. Previous approaches based on bone biopsy and discectomy exhibit important methodological limitations. Purpose The objective of this study was to assess the C3–C4 intervertebral disc (IVD), C3 vertebral body cancellous bone, and subcutaneous adipose tissue (SCT) pharmacokinetics of cefuroxime by use of microdialysis in a large animal model. Study Design This was a single-dose, dense sampling large animal study of cefuroxime spine penetration. Methods Ten female pigs were assigned to receive 1,500 mg of cefuroxime intravenously over 15 minutes. Measurements of cefuroxime were obtained from plasma, SCT, vertebral cancellous bone, and IVD for 8 hours thereafter. Microdialysis was applied for sampling in solid tissues. Results For both IVD and vertebral cancellous bone, the area under the concentration curve from zero to the last measured value (AUC0–last ) was significantly lower than that of free plasma. As estimated by the ratio of tissue AUC0–last to plasma AUC0–last , tissue penetration (95% confidence interval) of cefuroxime was significantly incomplete for the IVD 0.78 (0.57; 0.99), whereas for vertebral cancellous bone 0.78 (0.51; 1.04) and SCT 0.94 (0.73; 1.15) it was not. The penetration of cefuroxime from plasma to the IVD was delayed, and the maximal concentration and the elimination of cefuroxime were also reduced compared with both SCT and vertebral cancellous bone. Because of this delay in elimination of cefuroxime, the time with concentrations above the minimal inhibitory concentration (T&gt;MIC ) was significantly longer in the IVD compared with the remaining compartments up to MICs of 6 µg/mL. Conclusions Microdialysis was successfully applied for serial assessment of the concentration of cefuroxime in the IVD and the vertebral cancellous bone. Penetration of cefuroxime from plasma to IVD was found to be incomplete and delayed, but because of a prolonged elimination, superior T&gt;MIC was found in the IVD up to MICs of 6 µg/mL.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Cefuroxime</subject><subject>Cefuroxime - pharmacokinetics</subject><subject>Cervical Vertebrae - chemistry</subject><subject>Female</subject><subject>Infusions, Intravenous</subject><subject>Intervertebral disc</subject><subject>Intervertebral Disc - chemistry</subject><subject>Microbial Sensitivity Tests</subject><subject>Microdialysis</subject><subject>Models, Animal</subject><subject>Orthopedics</subject><subject>Pharmacokinetics</subject><subject>Subcutaneous Fat - chemistry</subject><subject>Swine</subject><subject>Tissue penetration</subject><subject>Vertebra</subject><issn>1529-9430</issn><issn>1878-1632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqFkk9v1DAQxSMEoqXwDRDykUvCjJ3EyQUJVfypVAkk4Gw59gS8TeLFTir2zBdnVluKxIWTR_Z7M88_TVE8R6gQsH21q_I-LESVBGwqxAoUPijOsdNdia2SD7luZF_2tYKz4knOOwDoNMrHxZlsWwl93Z4Xvz59t2m2Lt5wrzW4LOIocli-TVT6mEk4GrcUf4aZRFjEPibHQi5XSreUVhqSnYQP2Qm7ePH3ytnF0TTFLYshssMTO2b2ejEcxBxcij7Y6ZBDflo8Gu2U6dndeVF8fff2y-WH8vrj-6vLN9elq1GvpYIG6hHA6tHhAHposR1ajU3dK-V9bwesx8ZL6aRrh77RvSIA1_kWUPKTuihenvruU_yxUV7NzLk5pF2IcxrUHTSodIcsrU9SjplzotHsU5htOhgEc8RvduaE3xzxG0TD-Nn24m7CNszk701_eLPg9UlA_M_bQMlkF4hJ-ZDIrcbH8L8J_zZwU1iCs9MNHSjv4pYWZmjQZGnAfD6uwHEDsOGWvdTqNwEVr4U</recordid><startdate>20160301</startdate><enddate>20160301</enddate><creator>Hanberg, Pelle, MD-student</creator><creator>Bue, Mats, MD-student, PhD-student</creator><creator>Birke Sørensen, Hanne, MD, PhD</creator><creator>Søballe, Kjeld, Professor, MD, DMSc</creator><creator>Tøttrup, Mikkel, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6845-1874</orcidid></search><sort><creationdate>20160301</creationdate><title>Pharmacokinetics of single-dose cefuroxime in porcine intervertebral disc and vertebral cancellous bone determined by microdialysis</title><author>Hanberg, Pelle, MD-student ; Bue, Mats, MD-student, PhD-student ; Birke Sørensen, Hanne, MD, PhD ; Søballe, Kjeld, Professor, MD, DMSc ; Tøttrup, Mikkel, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-30504f00a7fc1b07b616b67154933dd9ab14f5d22c2c6b95793e00c8d601214f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Cefuroxime</topic><topic>Cefuroxime - pharmacokinetics</topic><topic>Cervical Vertebrae - chemistry</topic><topic>Female</topic><topic>Infusions, Intravenous</topic><topic>Intervertebral disc</topic><topic>Intervertebral Disc - chemistry</topic><topic>Microbial Sensitivity Tests</topic><topic>Microdialysis</topic><topic>Models, Animal</topic><topic>Orthopedics</topic><topic>Pharmacokinetics</topic><topic>Subcutaneous Fat - chemistry</topic><topic>Swine</topic><topic>Tissue penetration</topic><topic>Vertebra</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hanberg, Pelle, MD-student</creatorcontrib><creatorcontrib>Bue, Mats, MD-student, PhD-student</creatorcontrib><creatorcontrib>Birke Sørensen, Hanne, MD, PhD</creatorcontrib><creatorcontrib>Søballe, Kjeld, Professor, MD, DMSc</creatorcontrib><creatorcontrib>Tøttrup, Mikkel, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The spine journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hanberg, Pelle, MD-student</au><au>Bue, Mats, MD-student, PhD-student</au><au>Birke Sørensen, Hanne, MD, PhD</au><au>Søballe, Kjeld, Professor, MD, DMSc</au><au>Tøttrup, Mikkel, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics of single-dose cefuroxime in porcine intervertebral disc and vertebral cancellous bone determined by microdialysis</atitle><jtitle>The spine journal</jtitle><addtitle>Spine J</addtitle><date>2016-03-01</date><risdate>2016</risdate><volume>16</volume><issue>3</issue><spage>432</spage><epage>438</epage><pages>432-438</pages><issn>1529-9430</issn><eissn>1878-1632</eissn><abstract>Abstract Background Pyogenic spondylodiscitis is associated with prolonged antimicrobial therapy and high relapse rates. Nevertheless, tissue pharmacokinetic studies of relevant antimicrobials in both prophylactic and therapeutic situations are still sparse. Previous approaches based on bone biopsy and discectomy exhibit important methodological limitations. Purpose The objective of this study was to assess the C3–C4 intervertebral disc (IVD), C3 vertebral body cancellous bone, and subcutaneous adipose tissue (SCT) pharmacokinetics of cefuroxime by use of microdialysis in a large animal model. Study Design This was a single-dose, dense sampling large animal study of cefuroxime spine penetration. Methods Ten female pigs were assigned to receive 1,500 mg of cefuroxime intravenously over 15 minutes. Measurements of cefuroxime were obtained from plasma, SCT, vertebral cancellous bone, and IVD for 8 hours thereafter. Microdialysis was applied for sampling in solid tissues. Results For both IVD and vertebral cancellous bone, the area under the concentration curve from zero to the last measured value (AUC0–last ) was significantly lower than that of free plasma. As estimated by the ratio of tissue AUC0–last to plasma AUC0–last , tissue penetration (95% confidence interval) of cefuroxime was significantly incomplete for the IVD 0.78 (0.57; 0.99), whereas for vertebral cancellous bone 0.78 (0.51; 1.04) and SCT 0.94 (0.73; 1.15) it was not. The penetration of cefuroxime from plasma to the IVD was delayed, and the maximal concentration and the elimination of cefuroxime were also reduced compared with both SCT and vertebral cancellous bone. Because of this delay in elimination of cefuroxime, the time with concentrations above the minimal inhibitory concentration (T&gt;MIC ) was significantly longer in the IVD compared with the remaining compartments up to MICs of 6 µg/mL. Conclusions Microdialysis was successfully applied for serial assessment of the concentration of cefuroxime in the IVD and the vertebral cancellous bone. Penetration of cefuroxime from plasma to IVD was found to be incomplete and delayed, but because of a prolonged elimination, superior T&gt;MIC was found in the IVD up to MICs of 6 µg/mL.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26620946</pmid><doi>10.1016/j.spinee.2015.11.031</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-6845-1874</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1529-9430
ispartof The spine journal, 2016-03, Vol.16 (3), p.432-438
issn 1529-9430
1878-1632
language eng
recordid cdi_proquest_miscellaneous_1780513781
source ScienceDirect Journals
subjects Animals
Anti-Bacterial Agents - pharmacokinetics
Cefuroxime
Cefuroxime - pharmacokinetics
Cervical Vertebrae - chemistry
Female
Infusions, Intravenous
Intervertebral disc
Intervertebral Disc - chemistry
Microbial Sensitivity Tests
Microdialysis
Models, Animal
Orthopedics
Pharmacokinetics
Subcutaneous Fat - chemistry
Swine
Tissue penetration
Vertebra
title Pharmacokinetics of single-dose cefuroxime in porcine intervertebral disc and vertebral cancellous bone determined by microdialysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T20%3A49%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20of%20single-dose%20cefuroxime%20in%20porcine%20intervertebral%20disc%20and%20vertebral%20cancellous%20bone%20determined%20by%20microdialysis&rft.jtitle=The%20spine%20journal&rft.au=Hanberg,%20Pelle,%20MD-student&rft.date=2016-03-01&rft.volume=16&rft.issue=3&rft.spage=432&rft.epage=438&rft.pages=432-438&rft.issn=1529-9430&rft.eissn=1878-1632&rft_id=info:doi/10.1016/j.spinee.2015.11.031&rft_dat=%3Cproquest_cross%3E1780513781%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-30504f00a7fc1b07b616b67154933dd9ab14f5d22c2c6b95793e00c8d601214f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1780513781&rft_id=info:pmid/26620946&rfr_iscdi=true